[House Report 118-520]
[From the U.S. Government Publishing Office]


118th Congress    }                                     {       Report
                        HOUSE OF REPRESENTATIVES
 2d Session       }                                     {      118-520

======================================================================



 
   CARDIOMYOPATHY HEALTH EDUCATION, AWARENESS, AND RESEARCH, AND AED 
                  TRAINING IN THE SCHOOLS ACT OF 2024

                                _______
                                

  May 22, 2024.--Committed to the Committee of the Whole House on the 
              State of the Union and ordered to be printed

                                _______
                                

Mrs. Rodgers of Washington, from the Committee on Energy and Commerce, 
                        submitted the following

                              R E P O R T

                        [To accompany H.R. 6829]

    The Committee on Energy and Commerce, to whom was referred 
the bill (H.R. 6829) to amend the Public Health Service Act to 
authorize and support the creation and dissemination of 
cardiomyopathy education, awareness, and risk assessment 
materials and resources to identify more at-risk families, to 
authorize research and surveillance activities relating to 
cardiomyopathy, and for other purposes, having considered the 
same, reports favorably thereon with an amendment and 
recommends that the bill as amended do pass.

                                CONTENTS

                                                                   Page
Purpose and Summary..............................................     5
Background and Need for Legislation..............................     5
Committee Action.................................................     5
Committee Votes..................................................     6
Oversight Findings and Recommendations...........................     8
New Budget Authority, Entitlement Authority, and Tax Expenditures     8
Congressional Budget Office Estimate.............................     8
Federal Mandates Statement.......................................     8
Statement of General Performance Goals and Objectives............     8
Duplication of Federal Programs..................................     8
Related Committee and Subcommittee Hearings......................     8
Committee Cost Estimate..........................................     9
Earmark, Limited Tax Benefits, and Limited Tariff Benefits.......     9
Advisory Committee Statement.....................................     9
Applicability to Legislative Branch..............................     9
Section-by-Section Analysis of the Legislation...................     9
Changes in Existing Law Made by the Bill, as Reported............    10

    The amendment is as follows:
  Strike all after the enacting clause and insert the 
following:

SECTION 1. SHORT TITLE.

  This Act may be cited as the ``Cardiomyopathy Health Education, 
Awareness, and Research, and AED Training in the Schools Act of 2024'' 
or the ``HEARTS Act of 2024''.

SEC. 2. CARDIOMYOPATHY HEALTH EDUCATION, AWARENESS, AND RESEARCH, AND 
                    AED TRAINING IN SCHOOLS.

  (a) In General.--The Public Health Service Act is amended by 
inserting after section 312 (42 U.S.C. 244) the following:

``SEC. 312A. MATERIALS AND RESOURCES TO INCREASE EDUCATION AND 
                    AWARENESS OF CARDIOMYOPATHY AMONG SCHOOL 
                    ADMINISTRATORS, EDUCATORS, AND FAMILIES.

  ``(a) Materials and Resources.--Not later than 18 months after the 
date of the enactment of the HEARTS Act of 2024, the Secretary, in 
consultation with the Director of the Centers for Disease Control and 
Prevention, shall develop public education materials and resources to 
be disseminated to school administrators, educators, school health 
professionals, coaches, families, guardians, caregivers, and other 
appropriate individuals. The materials and resources shall include--
          ``(1) information on the signs, symptoms, and risk factors 
        associated with high-risk cardiac conditions and genetic heart 
        rhythm abnormalities that may cause sudden cardiac arrest in 
        children, adolescents, and young adults, including--
                  ``(A) cardiomyopathy;
                  ``(B) long QT syndrome, Brugada syndrome, 
                catecholaminergic polymorphic ventricular tachycardia, 
                short QT syndrome, and Wolff-Parkinson-White syndrome; 
                and
                  ``(C) other high-risk cardiac conditions, as 
                determined by the Secretary;
          ``(2) guidelines regarding the placement of automated 
        external defibrillators in schools, early childhood education 
        programs, and child care centers;
          ``(3) training information on automated external 
        defibrillators and cardiopulmonary resuscitation; and
          ``(4) recommendations for how schools, early childhood 
        education programs, and child care centers can develop and 
        implement a cardiac emergency response plan.
  ``(b) Dissemination of Materials and Resources.--Not later than 30 
months after the date of the enactment of the HEARTS Act of 2024, the 
Secretary shall disseminate the materials and resources developed under 
subsection (a) in accordance with the following:
          ``(1) Distribution by state educational agencies.--The 
        Secretary shall make available such materials and resources to 
        State educational agencies to distribute--
                  ``(A) to school administrators, educators, school 
                health professionals, coaches, families, guardians, 
                caregivers, and other appropriate individuals, the 
                information developed under subsection (a)(1);
                  ``(B) to parents, guardians, or other caregivers, the 
                cardiomyopathy risk assessment developed pursuant to 
                section 312B(b)(1); and
                  ``(C) to school administrators, educators, school 
                health professionals, and coaches--
                          ``(i) the guidelines described in subsection 
                        (a)(2);
                          ``(ii) the training information described in 
                        subsection (a)(3); and
                          ``(iii) the recommendations described in 
                        subsection (a)(4).
          ``(2) Dissemination to health departments and 
        professionals.--The Secretary shall make available the 
        materials and resources developed under subsection (a) to State 
        and local health departments, pediatricians, hospitals, and 
        other health professionals, such as nurses and first 
        responders.
          ``(3) Posting on website.--
                  ``(A) CDC.--
                          ``(i) In general.--The Secretary, through the 
                        Director, shall post the materials and 
                        resources developed under subsection (a) on the 
                        public Internet website of the Centers for 
                        Disease Control and Prevention.
                          ``(ii) Additional information.--The Director 
                        is encouraged to maintain on such public 
                        Internet website such additional information 
                        regarding cardiomyopathy as deemed appropriate 
                        by the Director.
                  ``(B) State educational agencies.--State educational 
                agencies are encouraged to create public Internet 
                webpages dedicated to cardiomyopathy and post the 
                materials and resources developed under subsection (a) 
                on such webpages.
  ``(c) Definitions.--In this section:
          ``(1) The term `cardiomyopathy' means a heart disease that 
        affects the heart's muscle (myocardium)--
                  ``(A) the symptoms of which may vary from case to 
                case, including--
                          ``(i) cases in which no symptoms are present 
                        (asymptomatic); and
                          ``(ii) cases in which there are symptoms of a 
                        progressive condition that may result from an 
                        impaired ability of the heart to pump blood, 
                        such as fatigue, irregular heartbeats 
                        (arrhythmia), heart failure, and, potentially, 
                        sudden cardiac death; and
                  ``(B) the recognized types of which include dilated, 
                hypertrophic, restrictive, arrhythmogenic right 
                ventricular dysplasia, and left ventricular non-
                compaction.
          ``(2) The term `Director' means the Director of the Centers 
        for Disease Control and Prevention.
          ``(3) The terms `early childhood education program', 
        `elementary school', and `secondary school' have the meanings 
        given to those terms in section 8101 of the Elementary and 
        Secondary Education Act of 1965.
          ``(4) The term `school administrator' means a principal, 
        director, manager, or other supervisor or leader within an 
        elementary school, secondary school, State-based early 
        childhood education program, or child care center.
          ``(5) The term `school health professional' means a health 
        professional serving at an elementary school, secondary school, 
        State-based early childhood education program, or child care 
        center.

``SEC. 312B. ACTIVITIES RELATING TO CARDIOMYOPATHY.

  ``(a) Report on CDC National Cardiomyopathy Activities.--
          ``(1) In general.--Not later than 18 months after the date of 
        the enactment of the HEARTS Act of 2024, the Secretary, acting 
        through the Director of the Centers for Disease Control and 
        Prevention, shall submit to Congress a report on findings 
        generated from existing activities conducted by the Centers for 
        Disease Control and Prevention to improve the understanding of 
        the prevalence and epidemiology of cardiomyopathy across the 
        lifespan, from birth to adulthood, with particular interest in 
        the following:
                  ``(A) The natural history of individuals with 
                cardiomyopathy, in both the pediatric and adult 
                population.
                  ``(B) Estimates of cardiomyopathy-related emergency 
                department visits and hospitalizations, in both the 
                pediatric and adult population.
          ``(2) Public access.--Subject to paragraph (3), the report 
        submitted under this subsection shall be made available to the 
        public.
          ``(3) Privacy protections.--The Secretary shall ensure that 
        this subsection is carried out in a manner that complies with 
        all applicable privacy laws under Federal and State law.
  ``(b) Improving Risk Assessments for Individuals With 
Cardiomyopathy.--
          ``(1) In general.--The Secretary shall develop and make 
        publicly available a cardiomyopathy risk assessment for health 
        care providers and individuals. Such risk assessment shall, at 
        a minimum, include the following:
                  ``(A) Background information on the prevalence, 
                incidence, and health impact of cardiomyopathy, 
                including all forms of cardiomyopathy and their effects 
                on pediatric, adolescent, and adult individuals.
                  ``(B) A worksheet with variables and conditions for 
                an individual or health care provider to use in 
                assessing whether an individual is at risk for 
                cardiomyopathy.
                  ``(C) A worksheet with variables and stages of 
                progression for an individual or health care provider 
                to use in assessing whether and to what extent 
                cardiomyopathy has progressed in an individual.
                  ``(D) Guidelines on cardiomyopathy screenings for 
                individuals who are at risk for, or have a family 
                history of, cardiomyopathy.
          ``(2) Stakeholder input.--In carrying out paragraph (1), the 
        Director of the Centers for Disease Control and Prevention 
        shall seek input from external stakeholders including--
                  ``(A) representatives from national patient advocacy 
                organizations expert in all forms of cardiomyopathy;
                  ``(B) representatives from medical professional 
                societies that specialize in the care of adults and 
                pediatrics with cardiomyopathy; and
                  ``(C) representatives from other relevant Federal 
                agencies.
  ``(c) Definition.--In this section, the term `cardiomyopathy' has the 
meaning given to such term in section 312A.

``SEC. 312C. CARDIOMYOPATHY RESEARCH.

  ``(a) In General.--The Secretary, in consultation with the Director 
of the National Institutes of Health, may expand and coordinate 
research and related activities of the National Institutes of Health 
with respect to cardiomyopathy, which may include research with respect 
to--
          ``(1) causation of cardiomyopathy, including genetic causes 
        and molecular biomarkers;
          ``(2) long-term health outcomes in individuals with 
        cardiomyopathy, including infants, children, teenagers, adults, 
        and elderly individuals; and
          ``(3) studies using longitudinal data and retrospective 
        analysis to identify effective treatments and outcomes for 
        individuals with cardiomyopathy.
  ``(b) Nonduplication.--The Secretary shall ensure that any research 
and activities related to cardiomyopathy under this section do not 
unnecessarily duplicate activities, programs, or efforts of other 
agencies and offices within the Department of Health and Human 
Services.
  ``(c) NIH Report.--Not later than 18 months after the date of the 
enactment of the HEARTS Act of 2024, the Secretary, in consultation 
with the Director of the National Institutes of Health, shall submit to 
Congress a report--
          ``(1) outlining the ongoing research efforts of the National 
        Institutes of Health regarding cardiomyopathy; and
          ``(2) identifying--
                  ``(A) a research agenda regarding adult forms of 
                cardiomyopathy;
                  ``(B) plans for researching cardiomyopathy affecting 
                the pediatric population; and
                  ``(C) the areas of greatest need for such research.
  ``(d) Cardiomyopathy Defined.--In this section, the term 
`cardiomyopathy' has the meaning given to such term in section 312A.

``SEC. 312D. PROMOTING STUDENT ACCESS TO AEDS AND CPR.

  ``(a) In General.--The Secretary shall award grants to eligible 
entities to develop and implement a comprehensive program to promote 
student access to automated external defibrillators (in this section 
referred to as `AEDs') and cardiopulmonary resuscitation (in this 
section referred to as `CPR') in public elementary schools and 
secondary schools.
  ``(b) Use of Funds.--An eligible entity receiving a grant under 
subsection (a) may use funds received through such grant to carry out 
any of the following activities:
          ``(1) Developing and providing comprehensive materials to 
        establish AED and CPR programs in public elementary schools and 
        secondary schools.
          ``(2) Providing support for CPR and AED training programs in 
        such schools for students, staff, and related sports 
        volunteers.
          ``(3) Providing support for developing a cardiac emergency 
        response plan within such schools.
          ``(4) Purchasing AEDs that have been approved under section 
        515 of the Federal Food, Drug, and Cosmetic Act, cleared under 
        section 510(k) of such Act, or classified under section 
        513(f)(2) of such Act.
          ``(5) Purchasing necessary AED batteries and performing 
        necessary AED maintenance (such as by replacing AED pads) in 
        accordance with the labeling of the AED involved.
          ``(6) Replacing old and outdated AED and CPR equipment, 
        machinery, and educational materials.
  ``(c) Eligibility; Application.--To be eligible for a grant under 
subsection (a), an entity shall--
          ``(1) be a local educational agency (including a public 
        charter school operating as a local educational agency under 
        State law), in consultation with a qualified health care 
        entity; and
          ``(2) submit to the Secretary an application at such time, in 
        such manner, and containing such information as the Secretary 
        may reasonably require.
  ``(d) Definitions.--In this section:
          ``(1) ESEA terms.--The terms `elementary school', `local 
        educational agency', and `secondary school' have the meanings 
        given such terms in section 8101 of the Elementary and 
        Secondary Education Act of 1965.
          ``(2) Qualified health care entity.--The term `qualified 
        health care entity' means a health care entity that--
                  ``(A) is--
                          ``(i) a public entity; or
                          ``(ii) an organization that is described in 
                        section 501(c) of the Internal Revenue Code of 
                        1986 and exempt from taxation under section 
                        501(a) of such Code;
                  ``(B) demonstrates an ability to develop, train, and 
                implement a comprehensive program to promote student 
                access to defibrillation in public elementary and 
                secondary schools; and
                  ``(C) is qualified in providing technical assistance 
                in AED and CPR training.''.
  (b) Authorization of Appropriations.--Section 312(e) of the Public 
Health Service Act (42 U.S.C. 244(e)) is amended by striking the first 
sentence and inserting the following: ``For the purpose of carrying out 
this section and sections 312A, 312B, 312C, and 312D, there is 
authorized to be appropriated $25,000,000 for each of fiscal years 2025 
through 2029.''.

                          Purpose and Summary

    H.R. 6829 directs the Department of Health and Human 
Services (HHS) to develop and distribute certain educational 
materials and resources regarding cardiomyopathy, automated 
external defibrillators (AEDs), and cardiopulmonary 
resuscitation (CPR), to school administrators, educators, 
school health professionals, coaches, families, guardians, 
caregivers, State and local health departments, certain health 
professionals, and other relevant individuals. In addition, 
this bill would require the Secretary to submit a report to 
Congress on the Centers for Disease Control and Prevention's 
(CDC's) existing activities related to cardiomyopathy, as well 
as develop a risk assessment for individuals at risk of 
cardiomyopathy. This bill would also allow the Secretary, in 
consultation with the Director of the National Institutes of 
Health (NIH), to expand and coordinate research with respect to 
cardiomyopathy and requires a report on NIH's ongoing research 
efforts. The bill also includes a program to promote student 
access to AEDs and CPR in schools, including educational 
materials, training programs, and equipment.

                  Background and Need for Legislation

    This legislation authorizes and supports the development of 
a Cardiomyopathy Education and Awareness Program. This program 
would facilitate a coordinated effort to raise public awareness 
of cardiomyopathy, while working with communities to ensure 
they have the ability to address cardiac events as they occur. 
In the United States, more than 30,000 children in the U.S. are 
diagnosed with some form of cardiomyopathy.\1\ Generally, the 
immediate use of an automated external defibrillator (AED) or 
cardiopulmonary resuscitation (CPR) can double or triple the 
person's chance of survival.\2\
---------------------------------------------------------------------------
    \1\Children's Caridomyopathy Foundation, ``Vital Facts'', 2024. 
https://www.
childrenscardiomyopathy.org/pages/about-disease/vital-facts/.
    \2\American Heart Association, ``What Is an Automated External 
Defibrillator?'', 2023. https://www.heart.org/-/media/files/health-
topics/answers-by-heart/what-is-an-aed.pdf.
---------------------------------------------------------------------------

                            Committee Action

    On February 14, 2024, the Subcommittee on Health held a 
hearing on H.R. 6829. The title of the hearing was 
``Legislative Proposals to Support Patients and Caregivers.'' 
The Subcommittee received testimony from:
           Andy Shih, PhD, Chief Science Officer, 
        Autism Speaks;
           Corey Feist, JD, MBA, Co-Founder and CEO, 
        Dr. Lorna Breen Heroes' Foundation;
           Joanne Pike, DrPH, President and CEO, 
        Alzheimer's Association;
           Gordon Tomaselli, MD, Former President, 
        American Heart Association; Marilyn and Stanley M. Katz 
        Dean, Emeritus and Professor of Medicine, Albert 
        Einstein College of Medicine; Adjunct Professor of 
        Medicine, Johns Hopkins University School of Medicine;
           Michelle Whitten, President, CEO, and Co-
        Founder, Global Down Syndrome Foundation;
           Randy Strozyk, President, American Ambulance 
        Association; and
           Christina Annunziata, MD, PhD, Senior Vice 
        President of Extramural Discovery Science, American 
        Cancer Society.
    On March 12, 2024, the Subcommittee on Health met in open 
markup session and forwarded H.R. 6829, as amended, to the full 
Committee by a record vote of 24 yeas and 0 nays.
    On March 20, 2024, the full Committee on Energy and 
Commerce met in open markup session and ordered H.R. 6829, as 
amended, favorably reported to the House by a record vote of 42 
yeas and 0 nays.

                            Committee Votes

    Clause 3(b) of rule XIII requires the Committee to list the 
record votes on the motion to report legislation and amendments 
thereto. The following reflects the record votes taken during 
the Committee consideration:

    [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]

                 Oversight Findings and Recommendations

    Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of 
rule XIII, the Committee held a hearing and made findings that 
are reflected in this report.

   New Budget Authority, Entitlement Authority, and Tax Expenditures

    Pursuant to clause 3(c)(2) of rule XIII, the Committee 
finds that H.R. 6829 would result in no new or increased budget 
authority, entitlement authority, or tax expenditures or 
revenues.

                  Congressional Budget Office Estimate

    Pursuant to clause 3(c)(3) of rule XIII, at the time this 
report was filed, the cost estimate prepared by the Director of 
the Congressional Budget Office pursuant to section 402 of the 
Congressional Budget Act of 1974 was not available.

                       Federal Mandates Statement

    The Committee adopts as its own the estimate of Federal 
mandates prepared by the Director of the Congressional Budget 
Office pursuant to section 423 of the Unfunded Mandates Reform 
Act.

         Statement of General Performance Goals and Objectives

    Pursuant to clause 3(c)(4) of rule XIII, the general 
performance goal or objective of this legislation is to prevent 
deaths from cardiac arrest by providing information and 
resources that prepare schools to respond in the event of a 
cardiac emergency.

                    Duplication of Federal Programs

    Pursuant to clause 3(c)(5) of rule XIII, no provision of 
H.R. 6829 is known to be duplicative of another Federal 
program, including any program that was included in a report to 
Congress pursuant to section 21 of Public Law 111-139 or the 
most recent Catalog of Federal Domestic Assistance.

              Related Committee and Subcommittee Hearings

    Pursuant to clause 3(c)(6) of rule XIII, the following 
related hearing was used to develop or consider H.R. 6829:
           On February 14, 2024, the Subcommittee on 
        Health held a hearing on H.R. 6829. The title of the 
        hearing was ``Legislative Proposals to Support Patients 
        and Caregivers.'' The Subcommittee received testimony 
        from:
                   Andy Shih, PhD, Chief Science 
                Officer, Autism Speaks;
                   Corey Feist, JD, MBA, Co-Founder 
                and CEO, Dr. Lorna Breen Heroes' Foundation;
                   Joanne Pike, DrPH, President and 
                CEO, Alzheimer's Association;
                   Gordon Tomaselli, MD, Former 
                President, American Heart Association; Marilyn 
                and Stanley M. Katz Dean, Emeritus and 
                Professor of Medicine, Albert Einstein College 
                of Medicine; Adjunct Professor of Medicine, 
                Johns Hopkins University School of Medicine;
                   Michelle Whitten, President, 
                CEO, and Co-Founder, Global Down Syndrome 
                Foundation;
                   Randy Strozyk, President, 
                American Ambulance Association; and
                   Christina Annunziata, MD, PhD, 
                Senior Vice President of Extramural Discovery 
                Science, American Cancer Society.

                        Committee Cost Estimate

    Pursuant to clause 3(d)(1) of rule XIII, the Committee 
adopts as its own the cost estimate prepared by the Director of 
the Congressional Budget Office pursuant to section 402 of the 
Congressional Budget Act of 1974. At the time this report was 
filed, the estimate was not available.

       Earmark, Limited Tax Benefits, and Limited Tariff Benefits

    Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the 
Committee finds that H.R. 6829 contains no earmarks, limited 
tax benefits, or limited tariff benefits.

                      Advisory Committee Statement

    No advisory committees within the meaning of section 5(b) 
of the Federal Advisory Committee Act were created by this 
legislation.

                  Applicability to Legislative Branch

    The Committee finds that the legislation does not relate to 
the terms and conditions of employment or access to public 
services or accommodations within the meaning of section 
102(b)(3) of the Congressional Accountability Act.

             Section-by-Section Analysis of the Legislation


Section 1. Short title

    Section 1 provides that the Act may be cited as the 
``Cardiomyopathy Health Education, Awareness, and Research, and 
AED Training in the Schools Act of 2024'' or the ``HEARTS Act 
of 2024''.

Section 2. Cardiomyopathy health education, awareness, and research, 
        and AED training in schools

    Section 2 amends the Public Health Service Act to provide 
organization for the Cardiomyopathy Education and Awareness 
Program and authorizes this program through fiscal year 2029. 
This section implements a timeline for the submission of 
reports and the dissemination of educational materials. In 
addition, this section also seeks to expand and coordinate 
cardiomyopathy related research and establish a grant program 
to promote student access to automated external defibrillators 
(AEDs) and cardiopulmonary resuscitation (CPR).

         Changes in Existing Law Made by the Bill, as Reported

  In compliance with clause 3(e) of rule XIII of the Rules of 
the House of Representatives, changes in existing law made by 
the bill, as reported, are shown as follows (existing law 
proposed to be omitted is enclosed in black brackets, new 
matter is printed in italics, and existing law in which no 
change is proposed is shown in roman):

                       PUBLIC HEALTH SERVICE ACT




           *       *       *       *       *       *       *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE

           *       *       *       *       *       *       *



Part B--Federal-State Cooperation

           *       *       *       *       *       *       *



SEC. 312. PUBLIC ACCESS DEFIBRILLATION PROGRAMS.

  (a) In General.--The Secretary shall award grants to States, 
political subdivisions of States, Indian tribes, and tribal 
organizations to develop and implement public access 
defibrillation programs--
          (1) by training and equipping local emergency medical 
        services personnel, including firefighters, police 
        officers, paramedics, emergency medical technicians, 
        and other first responders, to administer immediate 
        care, including cardiopulmonary resuscitation and 
        automated external defibrillation, to cardiac arrest 
        victims;
          (2) by purchasing automated external defibrillators, 
        placing the defibrillators in public places where 
        cardiac arrests are likely to occur, and training 
        personnel in such places to administer cardiopulmonary 
        resuscitation and automated external defibrillation to 
        cardiac arrest victims;
          (3) by setting procedures for proper maintenance and 
        testing of such devices, according to the guidelines of 
        the manufacturers of the devices;
          (4) by providing training to members of the public in 
        cardiopulmonary resuscitation and automated external 
        defibrillation;
          (5) by integrating the emergency medical services 
        system with the public access defibrillation programs 
        so that emergency medical services personnel, including 
        dispatchers, are informed about the location of 
        automated external defibrillators in their community; 
        and
          (6) by encouraging private companies, including small 
        businesses, to purchase automated external 
        defibrillators and provide training for their employees 
        to administer cardiopulmonary resuscitation and 
        external automated defibrillation to cardiac arrest 
        victims in their community.
  (b) Preference.--In awarding grants under subsection (a), the 
Secretary shall give a preference to a State, political 
subdivision of a State, Indian tribe, or tribal organization 
that--
          (1) has a particularly low local survival rate for 
        cardiac arrests, or a particularly low local response 
        rate for cardiac arrest victims; or
          (2) demonstrates in its application the greatest 
        commitment to establishing and maintaining a public 
        access defibrillation program.
  (c) Use of Funds.--A State, political subdivision of a State, 
Indian tribe, or tribal organization that receives a grant 
under subsection (a) may use funds received through such grant 
to--
          (1) purchase automated external defibrillators that 
        have been approved, or cleared for marketing, by the 
        Food and Drug Administration;
          (2) provide automated external defibrillation and 
        basic life support training in automated external 
        defibrillator usage through nationally recognized 
        courses;
          (3) provide information to community members about 
        the public access defibrillation program to be funded 
        with the grant;
          (4) provide information to the local emergency 
        medical services system regarding the placement of 
        automated external defibrillators in public places;
          (5) produce materials to encourage private companies, 
        including small businesses, to purchase automated 
        external defibrillators;
          (6) establish an information clearinghouse, that 
        shall be administered by an organization that has 
        substantial expertise in pediatric education, pediatric 
        medicine, and electrophysiology and sudden death, that 
        provides information to increase public access to 
        defibrillation in schools; and
          (7) further develop strategies to improve access to 
        automated external defibrillators in public places.
  (d) Application.--
          (1) In general.--To be eligible to receive a grant 
        under subsection (a), a State, political subdivision of 
        a State, Indian tribe, or tribal organization shall 
        prepare and submit an application to the Secretary at 
        such time, in such manner, and containing such 
        information as the Secretary may reasonably require.
          (2) Contents.--An application submitted under 
        paragraph (1) shall--
                  (A) describe the comprehensive public access 
                defibrillation program to be funded with the 
                grant and demonstrate how such program would 
                make automated external defibrillation 
                accessible and available to cardiac arrest 
                victims in the community;
                  (B) contain procedures for implementing 
                appropriate nationally recognized training 
                courses in performing cardiopulmonary 
                resuscitation and the use of automated external 
                defibrillators;
                  (C) contain procedures for ensuring direct 
                involvement of a licensed medical professional 
                and coordination with the local emergency 
                medical services system in the oversight of 
                training and notification of incidents of the 
                use of the automated external defibrillators;
                  (D) contain procedures for proper maintenance 
                and testing of the automated external 
                defibrillators, according to the labeling of 
                the manufacturer;
                  (E) contain procedures for ensuring 
                notification of local emergency medical 
                services system personnel, including 
                dispatchers, of the location and type of 
                devices used in the public access 
                defibrillation program; and
                  (F) provide for the collection of data 
                regarding the effectiveness of the public 
                access defibrillation program to be funded with 
                the grant in affecting the out-of-hospital 
                cardiac arrest survival rate.
  (e) Authorization of Appropriations.--[For the purpose of 
carrying out this section, there are authorized to be 
appropriated $25,000,000 for for each of fiscal years 2003 
through 2014.] For the purpose of carrying out this section and 
sections 312A, 312B, 312C, and 312D, there is authorized to be 
appropriated $25,000,000 for each of fiscal years 2025 through 
2029. Not more than 10 percent of amounts received under a 
grant awarded under this section may be used for administrative 
expenses.

SEC. 312A. MATERIALS AND RESOURCES TO INCREASE EDUCATION AND AWARENESS 
                    OF CARDIOMYOPATHY AMONG SCHOOL ADMINISTRATORS, 
                    EDUCATORS, AND FAMILIES.

  (a) Materials and Resources.--Not later than 18 months after 
the date of the enactment of the HEARTS Act of 2024, the 
Secretary, in consultation with the Director of the Centers for 
Disease Control and Prevention, shall develop public education 
materials and resources to be disseminated to school 
administrators, educators, school health professionals, 
coaches, families, guardians, caregivers, and other appropriate 
individuals. The materials and resources shall include--
          (1) information on the signs, symptoms, and risk 
        factors associated with high-risk cardiac conditions 
        and genetic heart rhythm abnormalities that may cause 
        sudden cardiac arrest in children, adolescents, and 
        young adults, including--
                  (A) cardiomyopathy;
                  (B) long QT syndrome, Brugada syndrome, 
                catecholaminergic polymorphic ventricular 
                tachycardia, short QT syndrome, and Wolff-
                Parkinson-White syndrome; and
                  (C) other high-risk cardiac conditions, as 
                determined by the Secretary;
          (2) guidelines regarding the placement of automated 
        external defibrillators in schools, early childhood 
        education programs, and child care centers;
          (3) training information on automated external 
        defibrillators and cardiopulmonary resuscitation; and
          (4) recommendations for how schools, early childhood 
        education programs, and child care centers can develop 
        and implement a cardiac emergency response plan.
  (b) Dissemination of Materials and Resources.--Not later than 
30 months after the date of the enactment of the HEARTS Act of 
2024, the Secretary shall disseminate the materials and 
resources developed under subsection (a) in accordance with the 
following:
          (1) Distribution by state educational agencies.--The 
        Secretary shall make available such materials and 
        resources to State educational agencies to distribute--
                  (A) to school administrators, educators, 
                school health professionals, coaches, families, 
                guardians, caregivers, and other appropriate 
                individuals, the information developed under 
                subsection (a)(1);
                  (B) to parents, guardians, or other 
                caregivers, the cardiomyopathy risk assessment 
                developed pursuant to section 312B(b)(1); and
                  (C) to school administrators, educators, 
                school health professionals, and coaches--
                          (i) the guidelines described in 
                        subsection (a)(2);
                          (ii) the training information 
                        described in subsection (a)(3); and
                          (iii) the recommendations described 
                        in subsection (a)(4).
          (2) Dissemination to health departments and 
        professionals.--The Secretary shall make available the 
        materials and resources developed under subsection (a) 
        to State and local health departments, pediatricians, 
        hospitals, and other health professionals, such as 
        nurses and first responders.
          (3) Posting on website.--
                  (A) CDC.--
                          (i) In general.--The Secretary, 
                        through the Director, shall post the 
                        materials and resources developed under 
                        subsection (a) on the public Internet 
                        website of the Centers for Disease 
                        Control and Prevention.
                          (ii) Additional information.--The 
                        Director is encouraged to maintain on 
                        such public Internet website such 
                        additional information regarding 
                        cardiomyopathy as deemed appropriate by 
                        the Director.
                  (B) State educational agencies.--State 
                educational agencies are encouraged to create 
                public Internet webpages dedicated to 
                cardiomyopathy and post the materials and 
                resources developed under subsection (a) on 
                such webpages.
  (c) Definitions.--In this section:
          (1) The term ``cardiomyopathy'' means a heart disease 
        that affects the heart's muscle (myocardium)--
                  (A) the symptoms of which may vary from case 
                to case, including--
                          (i) cases in which no symptoms are 
                        present (asymptomatic); and
                          (ii) cases in which there are 
                        symptoms of a progressive condition 
                        that may result from an impaired 
                        ability of the heart to pump blood, 
                        such as fatigue, irregular heartbeats 
                        (arrhythmia), heart failure, and, 
                        potentially, sudden cardiac death; and
                  (B) the recognized types of which include 
                dilated, hypertrophic, restrictive, 
                arrhythmogenic right ventricular dysplasia, and 
                left ventricular non-compaction.
          (2) The term ``Director'' means the Director of the 
        Centers for Disease Control and Prevention.
          (3) The terms ``early childhood education program'', 
        ``elementary school'', and ``secondary school'' have 
        the meanings given to those terms in section 8101 of 
        the Elementary and Secondary Education Act of 1965.
          (4) The term ``school administrator'' means a 
        principal, director, manager, or other supervisor or 
        leader within an elementary school, secondary school, 
        State-based early childhood education program, or child 
        care center.
          (5) The term ``school health professional'' means a 
        health professional serving at an elementary school, 
        secondary school, State-based early childhood education 
        program, or child care center.

SEC. 312B. ACTIVITIES RELATING TO CARDIOMYOPATHY.

  (a) Report on CDC National Cardiomyopathy Activities.--
          (1) In general.--Not later than 18 months after the 
        date of the enactment of the HEARTS Act of 2024, the 
        Secretary, acting through the Director of the Centers 
        for Disease Control and Prevention, shall submit to 
        Congress a report on findings generated from existing 
        activities conducted by the Centers for Disease Control 
        and Prevention to improve the understanding of the 
        prevalence and epidemiology of cardiomyopathy across 
        the lifespan, from birth to adulthood, with particular 
        interest in the following:
                  (A) The natural history of individuals with 
                cardiomyopathy, in both the pediatric and adult 
                population.
                  (B) Estimates of cardiomyopathy-related 
                emergency department visits and 
                hospitalizations, in both the pediatric and 
                adult population.
          (2) Public access.--Subject to paragraph (3), the 
        report submitted under this subsection shall be made 
        available to the public.
          (3) Privacy protections.--The Secretary shall ensure 
        that this subsection is carried out in a manner that 
        complies with all applicable privacy laws under Federal 
        and State law.
  (b) Improving Risk Assessments for Individuals With 
Cardiomyopathy.--
          (1) In general.--The Secretary shall develop and make 
        publicly available a cardiomyopathy risk assessment for 
        health care providers and individuals. Such risk 
        assessment shall, at a minimum, include the following:
                  (A) Background information on the prevalence, 
                incidence, and health impact of cardiomyopathy, 
                including all forms of cardiomyopathy and their 
                effects on pediatric, adolescent, and adult 
                individuals.
                  (B) A worksheet with variables and conditions 
                for an individual or health care provider to 
                use in assessing whether an individual is at 
                risk for cardiomyopathy.
                  (C) A worksheet with variables and stages of 
                progression for an individual or health care 
                provider to use in assessing whether and to 
                what extent cardiomyopathy has progressed in an 
                individual.
                  (D) Guidelines on cardiomyopathy screenings 
                for individuals who are at risk for, or have a 
                family history of, cardiomyopathy.
          (2) Stakeholder input.--In carrying out paragraph 
        (1), the Director of the Centers for Disease Control 
        and Prevention shall seek input from external 
        stakeholders including--
                  (A) representatives from national patient 
                advocacy organizations expert in all forms of 
                cardiomyopathy;
                  (B) representatives from medical professional 
                societies that specialize in the care of adults 
                and pediatrics with cardiomyopathy; and
                  (C) representatives from other relevant 
                Federal agencies.
  (c) Definition.--In this section, the term ``cardiomyopathy'' 
has the meaning given to such term in section 312A.

SEC. 312C. CARDIOMYOPATHY RESEARCH.

  (a) In General.--The Secretary, in consultation with the 
Director of the National Institutes of Health, may expand and 
coordinate research and related activities of the National 
Institutes of Health with respect to cardiomyopathy, which may 
include research with respect to--
          (1) causation of cardiomyopathy, including genetic 
        causes and molecular biomarkers;
          (2) long-term health outcomes in individuals with 
        cardiomyopathy, including infants, children, teenagers, 
        adults, and elderly individuals; and
          (3) studies using longitudinal data and retrospective 
        analysis to identify effective treatments and outcomes 
        for individuals with cardiomyopathy.
  (b) Nonduplication.--The Secretary shall ensure that any 
research and activities related to cardiomyopathy under this 
section do not unnecessarily duplicate activities, programs, or 
efforts of other agencies and offices within the Department of 
Health and Human Services.
  (c) NIH Report.--Not later than 18 months after the date of 
the enactment of the HEARTS Act of 2024, the Secretary, in 
consultation with the Director of the National Institutes of 
Health, shall submit to Congress a report--
          (1) outlining the ongoing research efforts of the 
        National Institutes of Health regarding cardiomyopathy; 
        and
          (2) identifying--
                  (A) a research agenda regarding adult forms 
                of cardiomyopathy;
                  (B) plans for researching cardiomyopathy 
                affecting the pediatric population; and
                  (C) the areas of greatest need for such 
                research.
  (d) Cardiomyopathy Defined.--In this section, the term 
``cardiomyopathy'' has the meaning given to such term in 
section 312A.

SEC. 312D. PROMOTING STUDENT ACCESS TO AEDS AND CPR.

  (a) In General.--The Secretary shall award grants to eligible 
entities to develop and implement a comprehensive program to 
promote student access to automated external defibrillators (in 
this section referred to as ``AEDs'') and cardiopulmonary 
resuscitation (in this section referred to as ``CPR'') in 
public elementary schools and secondary schools.
  (b) Use of Funds.--An eligible entity receiving a grant under 
subsection (a) may use funds received through such grant to 
carry out any of the following activities:
          (1) Developing and providing comprehensive materials 
        to establish AED and CPR programs in public elementary 
        schools and secondary schools.
          (2) Providing support for CPR and AED training 
        programs in such schools for students, staff, and 
        related sports volunteers.
          (3) Providing support for developing a cardiac 
        emergency response plan within such schools.
          (4) Purchasing AEDs that have been approved under 
        section 515 of the Federal Food, Drug, and Cosmetic 
        Act, cleared under section 510(k) of such Act, or 
        classified under section 513(f)(2) of such Act.
          (5) Purchasing necessary AED batteries and performing 
        necessary AED maintenance (such as by replacing AED 
        pads) in accordance with the labeling of the AED 
        involved.
          (6) Replacing old and outdated AED and CPR equipment, 
        machinery, and educational materials.
  (c) Eligibility; Application.--To be eligible for a grant 
under subsection (a), an entity shall--
          (1) be a local educational agency (including a public 
        charter school operating as a local educational agency 
        under State law), in consultation with a qualified 
        health care entity; and
          (2) submit to the Secretary an application at such 
        time, in such manner, and containing such information 
        as the Secretary may reasonably require.
  (d) Definitions.--In this section:
          (1) ESEA terms.--The terms ``elementary school'', 
        ``local educational agency'', and ``secondary school'' 
        have the meanings given such terms in section 8101 of 
        the Elementary and Secondary Education Act of 1965.
          (2) Qualified health care entity.--The term 
        ``qualified health care entity'' means a health care 
        entity that--
                  (A) is--
                          (i) a public entity; or
                          (ii) an organization that is 
                        described in section 501(c) of the 
                        Internal Revenue Code of 1986 and 
                        exempt from taxation under section 
                        501(a) of such Code;
                  (B) demonstrates an ability to develop, 
                train, and implement a comprehensive program to 
                promote student access to defibrillation in 
                public elementary and secondary schools; and
                  (C) is qualified in providing technical 
                assistance in AED and CPR training.

           *       *       *       *       *       *       *


                                  [all]